Company Filing History:
9 out of 363 
3 out of 2,078 
2 out of 654 
Years Active: 2008-2018
Title: Harold R Almond: Innovator in Hepatitis B Research
Introduction
Harold R Almond is a notable inventor based in Maple Glen, PA (US), recognized for his significant contributions to the field of hepatitis B research. With a total of 14 patents to his name, Almond has made strides in developing therapeutic solutions for chronic hepatitis B virus (HBV) infections.
Latest Patents
Among his latest patents, Almond has focused on the modulation of hepatitis B virus cccDNA transcription. His inventions provide small molecule inhibitors of HBV covalently closed circular (ccc) DNA, which are essential for managing chronic HBV. The compounds he developed achieve epigenetic modification of the cccDNA, histone modification, and histone deacetylase activity inhibition, thereby modulating HBV cccDNA. Furthermore, his patents include methods for treating or preventing HBV in subjects and for modulating cccDNA transcription of hepatitis B.
Career Highlights
Throughout his career, Harold R Almond has worked with prominent companies in the pharmaceutical industry, including Ortho-McNeil Pharmaceutical Corp. and Janssen Pharmaceutica NV. His work in these organizations has contributed to advancements in medical treatments and therapeutic strategies.
Collaborations
Almond has collaborated with several professionals in his field, including Michael Nicholas Greco and Michael Hawkins. These collaborations have likely enhanced the development and implementation of his innovative ideas.
Conclusion
Harold R Almond's work in hepatitis B research exemplifies the impact of innovation in the medical field. His patents and collaborations reflect a commitment to improving therapeutic options for chronic HBV, showcasing the importance of inventors in advancing healthcare solutions.